Lovesac, Avidity Biosciences, Veritone And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
1. Lovesac's Q2 losses of 45 cents beat expectations of 71 cents. 2. Quarterly sales of $160.53M exceeded estimates of $160.23M. 3. EPS guidance for FY2026 was significantly reduced from $0.80-$1.36 to $0.52-$1.05. 4. Shares tumbled 13% in pre-market trading to $18.05. 5. U.S. stock futures showed small gains with Dow up 0.2%.